How to Make Real-World Evidence Regulatory-Ready: Design, Governance & Early Engagement for Successful Submissions
Real-world evidence (RWE) is reshaping how regulatory affairs teams plan, prepare, and defend product submissions. Regulators are increasingly accepting RWE to support label expansions, safety monitoring, and even primary efficacy claims for certain products. To maximize RWE’s regulatory value, teams must combine sound study design, rigorous data governance, and proactive regulatory engagement.What makes RWE persuasive for regulators
– Relevance: Data must address specific regulatory questions—effectiveness in routine practice, long-term safety, or comparative effectiveness against alternatives.
– Fit-for-purpose quality: Sources such as electronic health records, registries, claims databases, and patient-generated data can be acceptable when completeness, accuracy, and consistency meet expectations.
– Transparency: Clear documentation of data provenance, curation steps, and analysis plans builds confidence in findings.
Practical steps to create regulatory-ready RWE
1.
Define the regulatory question first
Begin with the decision you want regulators to make.
Tailor endpoints, populations, and comparators to that objective so data collection and analysis are purpose-built rather than retrofitted.
2.
Establish robust data governance
Implement standards for data lineage, consent, de-identification, and audit trails. Maintain an accessible data dictionary, mapping rules, and version control.
This reduces regulatory friction and speeds review.
3. Use fit-for-purpose study designs
Emulate target trial principles where possible.
Pre-specify inclusion/exclusion criteria, exposure windows, and outcome definitions. Sensitivity analyses and negative controls strengthen causal inference when randomized evidence is limited.
4. Pre-plan statistical and methodological approaches
Select appropriate methods for confounding control (propensity scores, matching, weighting) and missing data. Pre-register protocols and analysis plans to demonstrate that results were not data-dredged post hoc.
5.
Engage regulators early and often
Request scientific advice or pre-submission meetings to align on acceptable data sources, endpoints, and analytical approaches. Regulators can offer guidance on whether proposed RWE will be adequate for the intended regulatory claim.
Cross-jurisdiction considerations
Regulatory expectations for RWE vary across regions. Align global submissions by mapping differences in acceptable data sources, privacy requirements, and evidentiary thresholds. Consider modular dossier approaches to reuse core data elements while adapting region-specific sections.
Privacy and ethical compliance
Comply with applicable privacy frameworks and informed consent requirements. When linking datasets or using patient-generated data, prioritize secure processes and clear governance to mitigate re-identification risk. Document ethics approvals and patient consent pathways in submission materials.
Operationalizing RWE within regulatory functions
– Build multidisciplinary teams: clinicians, epidemiologists, statisticians, data engineers, and regulatory strategists should collaborate from project initiation.
– Invest in interoperable platforms: standardize data models and terminologies to accelerate curation and analysis across multiple sources.
– Develop templates and libraries: standardized protocol, methods, and reporting templates streamline repetitive tasks and improve consistency.
Measuring success and maintaining credibility
Evaluate RWE studies not only on regulatory outcomes but on reproducibility and stakeholder trust.
Publish methods transparently when feasible, and maintain a living repository of methodological improvements and regulatory feedback to refine future efforts.
Real-world evidence offers a powerful complement to traditional clinical trials when handled strategically. With careful design, rigorous governance, and early regulatory dialogue, RWE can materially strengthen submissions, support lifecycle management, and demonstrate product value in real-world settings.